Statistics about Health, Pharma & Medtech in Japan
Statistics
- Nipro's operating income 2013-2022
- Paramount Bed Holdings' net sales FY 2022, by product
- Takeda Pharmaceutical's net income FY 2013-2022
- Takeda Pharmaceutical's number of employees FY 2013-2022
- Terumo's revenue FY 2013-2022
- Nipro's R&D expenditure FY 2014-2023
- Nipro's sales share FY 2023, by business
- Towa Pharmaceutical's employee numbers FY 2012-2017
- Otsuka Holdings' female managers ratio 2014-2020
- Forecast: medical and dental instruments manufacturing revenue Japan 2008-2018
- Towa Pharmaceutical's profit FY 2012-2017
- Astellas Pharma's net profit FY 2013-2022
- Industry revenue of “Ophthalmic goods, including frames“ in Japan 2012-2024
- Sawai's drug sales share in Japan FY 2018, by institution
- Pharmaceutical companies in Japan: Revenue and profit
- Chugai Pharmaceutical's R&D expenditure 2013-2022
- Sawai Group's R&D expenditure FY 2013-2022
- Sysmex's net sales FY 2013-2022
- Olympus Corporation's total assets FY 2014-2023
- Blood analyzer market size in Japan FY 2015-2022
- Companies with the highest number of medical device patent registrations Japan 2022
- Nipro's employee numbers 2017, by region
- Daiichi Sankyo's R&D expenditure FY 2013-2022
- R&D spending of pharmaceutical companies Japan FY 2015-2022
- Market size osteoporosis drug market Japan 2014-2024
- Medicated cosmetics production quantity in Japan 2016, by item
- Sawai Group's net income FY 2013-2022
- Breakdown production sanitary materials Japan 2018, by product
- R&D spending of pharmaceutical companies in relation to sales Japan FY 2015-2022
- Chugai Pharmaceutical's revenue 2013-2022
- Chugai Pharmaceutical's operating profit FY 2013-2022
- Paramount Bed Holdings' operating income FY 2015-2022
- Dental device and material market size in Japan FY 2010-2019
- Most popular sales channels for FemTech services among women Japan 2022
- Ono Pharmaceutical's number of employees FY 2013-2022
- Paramount Bed Holdings' total assets FY 2015-2022
- Paramount Bed Holdings' net sales FY 2015-2022
- Olympus Corporation's revenue FY 2014-2023
- Pharmaceutical market size Japan 2008-2015
- Sawai Pharmaceutical's number of patents FY 2013-2022
- Nichi-Iko's sales revenue FY 2013-2022
- Nipro's medical-related net sales FY 2014-2023
- Device lag of new medical devices Japan FY 2011-2020
- R&D expenditure of leading pharmaceutical manufacturers Japan FY 2022
- Paramount Bed Holdings' share of net sales FY 2021, by product
- Nipro's pharma packaging-related operating income 2013-2022
- Towa Pharmaceutical's total assets FY 2012-2017
- Major pharmaceutical companies in prescription drug sales Japan 2022, by distributor
- Otsuka Holdings' R&D ratio to revenue FY 2013-2022
- Otsuka Holdings' operating income FY 2013-2022
- Foreign major pharmaceutical companies' share Japan 2015
- Production value of medicated cosmetics Japan 2022, by category
- Total prescription drug revenues in Japan from top 10 companies 2015
- Production value share of medical devices Japan 2018, by sub-therapeutic category
- Generics drug market size Japan 2005-2020
- Sawai Pharmaceutical's total assets FY 2011-2020
- Number of approved new medical devices Japan FY 2013-2022, by year of submission
- Astellas Pharma's total assets FY 2013-2022
- Forecast: electromedical equipment manufacturing revenue Japan 2008-2018
- Major drug manufacturers Japan FY 2020, by wholesalers' sales share
- Medical diagnostics device market size Japan FY 2013-2024
- Share of prescription drug market Japan 2010-2019 , by category
- Medical technology revenue in Japan 2019-2029, by segment
- Olympus Corporation's revenue share FY 2023, by segment
- AI systems for assisting diagnoses and treatment market size Japan 2021-2027
- Production value of hair remedies Japan 2022, by category
- Sawai Pharmaceutical's number of employees FY 2013-2022
- Takeda Pharmaceutical's revenue FY 2013-2022
- Revenue of the medical technology industry in Japan 2019-2029
- Chugai pharmaceutical's sales share 2022, by disease area
- Sysmex's number of employees FY 2013-2022
- Japanese pharmaceutical companies top acquisitions as of 2014
- Breakdown of quasi-drugs production in Japan 2016, by region
- Major drug manufacturers Japan 2017, by number of products
- Fuji Pharma's sales distribution FY 2022, by therapeutic category
- Value of imported pharmaceutical drugs to Japan 2022, by region
- Quasi-drugs production plants in Japan 2016, by region
- Terumo's number of employees FY 2012-2021
- Takeda Pharmaceutical's revenue in Japan FY 2018-2022
- Astellas Pharma's R&D expenditure FY 2014-2023
- Production volume antidiarrheals intestinal regulators Japan 2021, by agent
- Breakdown value imported drugs Japan 2021, by category
- Value of imported pharmaceutical drugs to Japan 2013-2022
- Takeda Pharmaceutical's revenue in the U.S. FY 2018-2022
- Takeda Pharmaceutical's revenue in Asia FY 2018-2022
- CBD market size Japan 2021-2025, by type
- Sysmex's sales share 2022, by business
- Astellas Pharma's revenue FY 2014-2023
- Forecast of medical and nursing robot market size Japan FY 2021-2027
- Leading pharmaceutical companies Japan 2023, by R&D costs
- Value of exported pharmaceutical drugs from Japan 2022, by region
- Value medical device exports from Japan 2021, by region
- Value of exported pharmaceutical drugs from Japan 2021, by geographic region
- Daiichi Sankyo's total employees FY 2013-2022
- Otsuka Holdings' net sales FY 2014-2023
- Total asset of major companies in pharmaceutical industry Japan 2023
- Sysmex's operating profit FY 2013-2022
- Production value medical devices Japan 2018, by sub-therapeutic category
- Production value of pharmaceutical drugs Japan 2013-2022
- Takeda Pharmaceutical's revenue in Latin America FY 2018-2022